Nkarta (NKTX) Other Non-Current Assets (2019 - 2026)
Nkarta's (NKTX) quarterly Other Non-Current Assets came in at $2.7 million in Q1 2026, down 39.14% year-on-year from $4.5 million in Q1 2025, and little changed quarter-over-quarter from $2.7 million in Q4 2025.
Nkarta (NKTX) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Nkarta's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 39.14% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a 39.14% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 32.41% from the prior year.
- Other Non-Current Assets steadied at $2.7 million in Q1 2026 per NKTX's latest filing, from $2.7 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $4.6 million in Q3 2024 and bottomed at $1.2 million in Q2 2022.
- The 5-year median for Other Non-Current Assets is $2.7 million (2022), against an average of $2.7 million.
- Across the five-year window, Other Non-Current Assets surged 253.75% in 2022 and plunged 60.77% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $1.8 million in 2022, then jumped by 48.27% to $2.7 million in 2023, then surged by 47.94% to $4.1 million in 2024, then plunged by 32.41% to $2.7 million in 2025, then changed by 0.0% to $2.7 million in 2026.
- Per Business Quant, the three latest NKTX Other Non-Current Assets figures stand at $2.7 million (Q1 2026), $2.7 million (Q4 2025), and $1.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | 2.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.74 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.97 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 4.06 Mn |
| Sep 30, 2024 | 4.64 Mn |
| Jun 30, 2024 | 2.74 Mn |
| Mar 31, 2024 | 2.74 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | 2.74 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | 1.85 Mn |
| Sep 30, 2022 | 2.74 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 1.51 Mn |
| Jun 30, 2021 | 452,000.00 |